Portage Biotech Inc., 10% Owner at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 169,762 shares at $30.08 ($5.1M) on 2018-01-09, disclosed to the SEC on 2018-01-09.
Open-market sale of $5.1M BHVN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.03 | 22,996 | $691K | 13.5% |
| 2 | $30.03 | 22,996 | $691K | 13.5% |
| 3 | $30.02 | 5,728 | $172K | 3.4% |
| 4 | $30.02 | 5,728 | $172K | 3.4% |
| 5 | $30.08 | 56,157 | $1.7M | 33.1% |
| 6 | $30.08 | 56,157 |
| $1.7M |
| 33.1% |
| Total | $30.06 avg | 169,762 | $5.1M | 100% |
| Filing → |
| BHVN | SELL | 2018-01-04 | $2.0M | — | Filing → |